Latest from ISC 2016

Can Stem Cell Treatment Benefit Stroke Recovery?

Can Stem Cell Treatment Benefit Stroke Recovery?

The novel treatment did not meet primary endpoints, however it did reduce hospitalization, adverse outcomes, and death.

Pregnancy in Older Age Elevates Hemorrhagic Stroke Risk

Pregnancy in Older Age Elevates Hemorrhagic Stroke Risk

Women with pregnancy at an advanced age had significantly higher rates of ischemic stroke, hemorrhagic stroke, myocardial infarction, and cardiovascular death.

Post-Stroke Bowel Obstruction Linked to Disability, Mortality

Post-Stroke Bowel Obstruction Linked to Disability, Mortality

Patients of advanced age, black race, and with comorbidities have a higher risk of post-stroke GIBO.

Stroke Survivor Care Costs Medicare Beneficiaries $40 Billion Annually

Stroke Survivor Care Costs Medicare Beneficiaries $40 Billion Annually

The average annual cost for providing care to a stroke survivor was $11,300.

Idarucizumab Promising in Dabigatran-Treated Patients With ICH

Idarucizumab Promising in Dabigatran-Treated Patients With ICH

REVERSE-AD is an ongoing phase 3 cohort study evaluating the reversal effects of idarucizumab on dabigatran.

MRI May Help Determine IV tPA Eligibility in Stroke of Unknown Onset

MRI May Help Determine IV tPA Eligibility in Stroke of Unknown Onset

Treatment with IV tPA appeared safe and feasible with stroke onset confirmation from MRI.

Natalizumab May Improve Clinical Outcomes in Ischemic Stroke

Natalizumab May Improve Clinical Outcomes in Ischemic Stroke

Improvements in Rankin Scale score, Stroke Impact Scale-16, and Montreal Cognitive Assessment were observed in the treatment group.

Stenosis May Be Responsible for More Acute Ischemic Strokes

Stenosis May Be Responsible for More Acute Ischemic Strokes

Some strokes attributable to large-artery atherosclerosis are not being recognized as such because of <50% stenosis.

Too Much, Too Little Sleep Can Increase Risk for Stroke

Too Much, Too Little Sleep Can Increase Risk for Stroke

Those who slept more than 8 hours had a 146% greater risk of stroke.

Pioglitazone May Prevent Recurrent Stroke, Heart Attack in Patients Without Diabetes

Pioglitazone May Prevent Recurrent Stroke, Heart Attack in Patients Without Diabetes

Patients taking pioglitazone saw a 24% reduction in risk for recurrent stroke or myocardial infarction compared to placebo.

Upcoming Meetings

Sign Up for Free e-newsletters